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The nose is the natural and preferred respiratory passageway. Nasal obstruction is a 
common symptom and the etiology of nasal obstruction may be anatomical, 
physiological or pathological. Nasal mucosal inflammation is the most common 
pathologic cause and besides viral colds, allergic rhinitis is the most frequent cause of 
nasal obstruction.  
Sensation of nasal obstruction may be subjective only. Perceptions often differ 
making it difficult to quantify by subjective complaints or clinical examinations 
alone. Therefore concurrent subjective assessment and objective measurement is 
advantageous. Subjective assessment can be made using a visual analogue scale or a 
point symptom score. There is still a need for a universally accepted objective 
procedure. Often one or more methods are used to complement each other.  
Acoustic rhinometry (AR) defines objectively nasal cavity patency by acoustic 
reflections. It measures cross-sectional areas (CSAs) and internal nasal cavity volume 
(NV). However, methodological aspects of measurements may vary recordings and 
therefore a standardized procedure should be formulated in clinical and research 
applications of AR. The main objective of the present thesis is to validate the 
reliability of AR in the assessment of the nasal airway and to establish reference 
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values for nasal patency that can serve as a basis for further studies. This thesis 
consists of following experimental aspects: (1) Determination of standardized values 
and factors effecting normal nasal cavity dimensions in healthy individuals; (2) 
Validation of the use and reliability of AR, and its physical limitations in some 
pathological conditions in nasal cavity and paranasal sinuses; (3) Implications of AR 
in clinical and research works; and (4) Reviewing  the recent advancements of 
procedural techniques, standardization and validation of AR.  
Several topographical measurements for AR have been introduced, such as minimal 
CSA (MCA), CSA-3.3, 4.0 and 6.4 cm from the nostril and NV from 1 to 5 cm from 
the nostril. However there is no unvarying expert agreement on the significance of 
each measurement. In our study MCA appeared to be most sensitive and CSA 6.4 to 
be least reliable. We have proposed an MCA value of 0.74 ± 0.03 cm 2 for 
standardization in our local population.  It has also been demonstrated that AR 
measurements are not affected by height, weight or body mass index (BMI). 
Validation of different AR measurements with subjective methods had not been 
adequately evaluated before. We demonstrated an inverse relationship between point 
symptom score and objective measurements of AR. The strongest relationship was 
between nasal symptom score and MCA, followed by CSA 3.3, CSA 4.0 and CSA 
6.4. With symptom scores of zero and one, there was a wider range of MCA but it is 
more specific with pathological conditions causing severe nasal obstruction (score 2 
and 3). 
Using nasal cavity models, two studies concluded that measurements beyond a 
significant constriction may be unreliable. In a nasal allergen challenge study, we 
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demonstrated when the MCA reached an area <0.2 cm2, measurements of CSA 3.3 
and CSA 4.0 were reduced by 60 – 70%.  
AR was utilized to measure changes in nasal patency following the administration of 
drugs. Nasal patency is one of the parameters that was used to compare the efficacy 
of three strategies (intra nasal corticosteroids, oral antihistamines or a combination of 
both) in the treatment of perennial allergic rhinitis (PAR). All three strategies had 
comparable efficacy and thus treatment should be based on patients’ preference, 
compliance, comfort and cost.  
In conclusion, standardization of AR measurements in the “normal nose” as 
compared to different types of structural and mucosal variations is important. Sources 
of error and physical limitations of AR measurements and procedural technique 
should be considered when using AR in clinic and research. 
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The nose is the natural and preferred respiratory passageway for all ages. However 
it’s not simply an expressway of the respiratory tract. It aids us in breathing the breath 
able, eating the edible and smelling the smell able. It has also been linked with 
reproductive physiology and extravagant aesthetic morphology. No wonder nowadays 
the nose is not merely the singular curiosity of Otorhinolaryngologists, but also of 
Pediatricians, Allergists, Speech Pathologists, Orthodontists and of course Plastic 
Surgeons 
The importance of an unobstructed nasal airway for a healthy existence has been 
emphasized since antiquity. Yet till today nasal obstruction remains a common 
symptom causing much distress. Nasal obstruction is characterized by insufficient 
airflow through the nose, which can be a subjective sensation, or the result of 
objective pathology [1]. Often, the doctor’s assessment of a perfectly patent nasal 
airway might differ with the patient’s complaint of an obstructed nose. Hence, 
subjective assessment along with objective measurement of the nasal airway will aid 
diagnosis, treatment, research and medico-legal documentation [2]. 
Acoustic rhinometry (AR) defines objectively nasal cavity dimensions by acoustic 
reflections. AR is a static test and independent of airflow [3]. It measures cross-
sectional areas (CSAs) and internal nasal cavity volumes (NVs). Several 
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topographical measurements of the area- or volume- distance have been introduced, 
such as MCA, CSA-3.3, 4.0 and 6.4 cm from the nostril and NV from 1 to 5 cm from 
the nostril. Although each measurement is suggested to represent a distal dimension 
of the nasal cavity, there is no uniform agreement among experts on the value and 
significance of each measurement in respect to the nasal cavity dimensions. 
Standardization of measurements, sources of error and physical limitations and 
validation of the procedure with other subjective and objective methods have not been 
adequately evaluated [4]. 
Adults with high relative body mass have an increased demand for oxygen and thus 
may have to breathe with higher frequency or larger volumes during each inspiration 
[5]. In addition, an increased relative BMI is related to increased oral and nasal 
pressures, as well as an increased nasal airflow rate. Since there are higher airflow 
rates in subjects with high BMI, there might also be a correlation between BMI and 
nasal airway size and resistance to inspiratory airflow. AR is a useful method in 
measuring nasal airway size. Such measurements of individuals without any known 
nasal pathology will also be important in standardization of reference values for AR 
measurements.    
Allergic rhinitis may be effectively treated with intranasal corticosteroids and anti 
histamines, singly or as combination therapy. A short term intermittent therapy could 
be more acceptable for patients with perennial allergic rhinitis (PAR). As nasal 
obstruction is one of the major symptoms of PAR, an effective treatment should be 
able to improve nasal patency. AR may be used to measure objectively changes in 
nasal patency following administration of therapeutic measures.  
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2. BACKGROUND OF THESIS 
 
 
2.1. THE NOSE 
The nose has an osseo-cartilaginous framework. Figure 1 illustrates the external 
features of the nose. The nasal cavity is divided into two parts by the osseo-
cartilaginous nasal septum. The lateral wall of each cavity has turbinates or conchae 
projecting into the cavity and conforming it into a slit-like shape. The external bony 
opening of the nasal cavity is called the piriform aperture. The nasal vestibule is      
 
Figure 1: Features of the external nose [6] 
 
by Raza MT 
Nasal ala
Paranasion
Dorsum of the nose
Cartilaginous dorsum of the nose
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Tip of the nose 
Nasolabial sulcus
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located immediately posterior to this opening. The vestibule funnels air towards the 
nasal valve [7]. The nasal valve is the narrowest part of the nasal cavity [8]. The 
olfactory epithelium is located in the superior position of the cavity [9].  
Nasal cycle is the cyclic fluctuation in the congestion of the nasal mucosa, which 
results in rhythmic and bilateral reciprocal alternation of nasal airway patency. 
However a classical nasal cycle is not a universal phenomenon [10]. 
2.1.1 The Nasal Micro-Vasculature 
The nasal vessels [Table 1] play a central role in the pathophysiology of nasal 
obstruction. The nasal mucosal microvasculature is different from that of other parts 
of the respiratory tract [Table 2]. The capacitance vessels or blood sinuses  
 




Type    Vessel     
___________________________________________________ 
 
Resistance vessels  Arteries  
Arterioles 
 
Exchange vessels  Subepithelial capillaries 
    Periglandular capillaries 
 
Shunt vessels   Arteriovenous anastomoses 
 
Capacitance vessels  Venous sinusoids 
    Venules 
    Veins  
___________________________________________________ 
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expand the mucosa during congestion. There are three potential muscular 
mechanisms that could be responsible; (i) Thick layer of smooth muscle in sinus 
walls. Contraction and relaxation of this muscle may cause change in blood capacity. 
(ii) Contraction of the muscle in “throttle veins” at the exit from the sinuses which 
may distend the sinuses or (iii) Enlargement of the caliber of the arteriovenous 
anastomoses at the entry to the sinuses. Since the nose is enclosed in bone, the 
expansion must encroach on the airway lumen causing a blocked nose [11].  
 
Table 2: Difference between the microvasculature of the nasal mucosa with that of 
other parts of respiratory tract [11] 
__________________________________________________________________ 
 




Capacitance vessels  Highly developed            Absent or far less 
 frequent 
Arteriovenous  
anastomoses   Numerous   Absent 
 
Nasal cycle   Present   Not demonstrated 
__________________________________________________________________ 
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The nose, as an organ initiating reflexes affects itself and rest of the body [12]. Nasal 
blood vessels, glandular tissue and ciliary system may directly or indirectly influence 
nasal patency [8]. Nasal mucosal nerve supply probably provides the effective control 
of the nasal vasculature and the regulation of nasal patency and secretion. Its 
innervation includes parasympathetic, sympathetic, sensory/afferent, and somatic 
motor nerves, which combine in a variety of morphologic pathways [Figure 2] [12] 
Sympathetic arterial vasoconstriction reduces mucosal blood flow, sinusoidal filling, 
and mucosal thickness, and so restores nasal patency [13]. The actions of sensory 
nerves and parasympathetic reflexes play crucial roles in nasal pathology [14]. 
Neuropeptides also play an important role in the innervation of blood vessels and 
glands [15]. Nasal secretory tissue includes epithelial cells, submucosal glands, and 
relatively large anterior or lateral serous glands [8].  
2.1.2 The Normal Nose 
It is difficult to determine a standardized dimension for “the normal nose”. The 
anatomy of the nose varies with development, race, age and gender. Effects of BMI, 
height and weight are also a matter of study. Physiological events like nasal cycle and 
posture also affects normal nasal cavity dimensions. These factors must be taken into 
account in studies on environmental, clinical and pharmacological conditions. 
Nasal airway measurements in adults should be evaluated in relation to gender, 
whereas in children nasal values of boys and girls are comparable. In a healthy adult 
population the normal values of airflow rate and oral and nasal pressures, nasal CSAs 
would be expected to be slightly higher in men than in women [5, 16]. 
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Race is known to be one of the main important factors affecting nasal structure. A 
significant difference has been noted in Anglo-Saxon, Chinese and Negro noses [17]. 
Negroes seem to have a larger bony aperture and thus hypertrophied inferior turbinate 
(HIT) on anterior rhinoscopy may be a normal state. Thus Orientals might have an 
increased amount of vascular tissue than Caucasians or Negroes [18]. However no 
significant difference was demonstrated in between Chinese, Malay and Indian races 
[19] as well as in between Anglo-Saxon and Indian noses. 
The pediatric nasal cavity differs from adults in both size and proportion. The nose 
achieves adult proportions only at age 12. In children there is a specific anatomical 
structure in each age. Due to these differences the pediatric nasal cavity may be 
grouped into four different age groups; newborns, 1-4, 4-8 and 8-12 year olds [20, 21] 
Changing postures contributes significantly to the source of variation of nasal cavity 
patency. Nasal cavity dimensions decrease with change of posture from standing to 
supine and to lateral recumbent positions. It decreased when changing from sitting to 
supine postures but increased, when changing from sitting to standing postures. The 
mean volumes of the two sides of the nasal cavities are more significantly different in 
the sitting position but not in the supine posture, indicating that in the supine position 
the volume of the nasal cavities are more equal [22, 23]. 
2.1.3 Pathology of the Nose 
The anatomy of the nasal cavity is complicated. Septal deformities are often found in 
various locations. The impact on nasal patency by minor anteriorly deviated nasal 
septum (DNS) seems to be more important than posteriorly located major deformities. 
Validation of acoustic rhinometry   Raza MT 
 29
The anterior part of the nose including the pyriform opening contains the narrowest 
segment of the nose [24]. A long standing pronounced DNS might give rise to HIT 
due to compensatory changes. HIT may also be caused by concha bullosa or 
polypoidal mucosal transformation, and long-standing allergic or vasomotor rhinitis. 
Often it is due to a combination of several factors [25]. 
Adenoidal hypertrophy is the commonest cause of nasal obstruction in the pediatric 
population. It may cause marked morbidity as regards to respiratrory physiology, 
facial growth and middle ear function.  
Norback et al. [26] demonstrated that indoor air pollutants in schools might affect 
nasal patency. A decreased nasal patency at increased concentration of respiratory 
dust suggests a congestive effect of airborne particle pollutants. Their results 
suggested that different types of microorganisms might have different effects on nasal 
mucosa. Presence of Aspergillus spp and molds in the air decreased nasal patency. On 
the other hand a greater nasal patency at higher concentrations of bacteria was 
demonstrated. 
Almost without exception all patients with nasal polyps suffer from nasal blockage. 
This is constant although it will vary with the size and position of the polyps [27].  
Any space-occupying lesion from the nasal vestibule to the glottis can predispose to 
obstructive sleep apnea (OSA). Despite this most adult patients with OSA have no 
evident predisposing abnormality [28]. Nasal obstruction as a predisposing factor for 
OSA is still debatable [29-33]. Nasal polyps, DNS and rhinitis are causes of nasal 
obstruction that might predispose to OSA. It is therefore important during diagnosis 
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of OSA to examine the nose for assessment of nasal airway and reveal any cause of 
nasal obstruction [28]. Although surgical correction of nasal obstruction does not 
improve OSA consistently, nasal obstruction correction is suggested to be included in 
the overall treatment plan for OSA [29, 34, 35]. 
The most common pathological cause of nasal obstruction is nasal mucosal 
inflammation. If viral colds are excluded, allergic rhinitis has become the commonest 
cause of nasal obstruction [36]. Allergic rhinitis affects approximately 10-20% of the 
world population [37-40]. Nasal obstruction is the most common symptom of PAR, 
and, although rhinorrhea is more common in seasonal allergic rhinitis (SAR), 
obstruction is still significant in many patients [41]. In a Singapore community health 
survey, nasal obstruction was the most prevalent identified nasal symptom (15.8%), 
compared to sneezing (11.7%), rhinorrhea (10.6%) and nasal itch (10.2%) [42]. In 
patients with PAR, continuous allergen exposure causes a persistent mucosal 
inflammation and thus persistent nasal obstruction. Control of nasal obstruction in 
PAR is thus important, and since it must be treated all year around; treatment choices, 
costs, and compliance all become important public health issues [1].  
2.2 NASAL PATENCY 
2.2.1 Definition 
Patency is “the state of being freely open or exposed.” Thus nasal patency can be 
defined as “an objective measurement of how open the nose is”.  If the word patency 
is used in a correct way, nasal patency measurements should comprise CSAs and 
NVs. The practical useful methods for measurement include AR, computer aided 
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tomography (CT) scan and magnetic resonance imaging (MRI). However, recording 
nasal airflow with or without simultaneous pressure recordings is often included 
among methods (Rhinomanometry and nasal peak flow) for measuring nasal patency 
[36, 43]. 
2.2.2 Factors Affecting Nasal Patency 
Inflammation of the nasal mucosa, whatever the cause, is the most common 
pathologic cause of nasal obstruction. Etiology of nasal obstruction may be 
anatomical (DNS), physiological (nasal cycle, posture) or pathological (nasal polyp, 
foreign body). Nasal obstruction may be unilateral or bilateral, continuous or 
intermittent (at night, after exercise). If viral colds are excluded, allergic rhinitis has 
become the most common cause of nasal obstruction [1, 36]. Body temperature, 
posture and exercise also influence nasal patency [8] 
Decreased nasal patency is not always accompanied by increased nasal airway 
resistance, decreased nasal peak flow or reduced cavity dimensions [36]. Often the 
sensation of impaired nasal patency may be subjective only (atrophic rhinitis) and 
perception may vary from person to person. Sensation of nasal patency may also be 
related to nasal passage temperature. The nasal vestibule contains a dense distribution 
of cold receptors supplied by trigeminal nerve. Stimulation of the cold receptors 
misinterpret the sensory information to the brain leading to the subjective sensation of 
increased nasal patency in the absence of objective increase in nasal patency [44, 45]. 
L-menthol stimulates the cold receptors [46]. The cooler the nasal lining or the 
greater the drop in temperature on inspiration, the clearer the nose will feel [47, 48]. 
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No thermoreceptors were demonstrated in the nasal cavum (the major part of the 
nasal cavities that is lined by respiratory mucosa) [49]. 
2.3 ASSESSMENT OF NASAL OBSTRUCTION 
The importance of a patent nasal airway for healthy existence has been emphasized 
since antiquity. Yet till today nasal obstruction remains a common symptom causing 
much distress and is one of the most common symptoms encountered in primary care 
and specialist clinics. It is difficult to quantify by subjective complaints or clinical 
examinations alone, hence concurrent subjective assessment and objective 
measurement of the nasal airway is critical for clinic and research [1, 2]. 
2.3.1 Subjective Assessment of Nasal Obstruction 
Subjective assessment of nasal obstruction can be made using a visual analogue scale 
(VAS) or a point symptom score. 
Visual analogue scale 
The core question of the VAS is “How do you feel on a scale from 0 to 100 (or 10)?” 
[50]. The scale is a self-reporting device that measures the magnitude of internal 
state, (in this case nasal obstruction). Conventionally, the VAS is a line that is either 
vertically or horizontally oriented with anchors placed at both poles from 0 (no 
obstruction) to 10 [51, 52] or 100 [53] (severe or complete obstruction). Participants 
place a mark somewhere along the line that best indicates the magnitude of nasal 
obstruction according to their perception [Figure 3]. They are often asked to mark 
their discomfort for each nostril separately [53] or for combined sensation [51].  
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Subjective point symptom score 
In a point symptom score [2, 54] the degree of nasal obstruction is categorized in 
well-defined points [Table 3]. The participant chooses the point, which associates 
best with the severity of nasal obstruction according to their perception.  
Limitation of subjective assessment of nasal obstruction 
It is difficult to estimate the extent and severity of nasal obstruction subjectively. 
Nasal obstruction is often a complaint of atrophic rhinitis, a disorder with wide nasal 
cavities [36]. Damage to trigeminal sensory nerve endings can cause a sensation of 
nasal stuffiness and similarly inhalation of menthol can cause a subjective 
improvement in nasal sensation of airflow without any change in nasal resistance 
[55]. What one patient considers nasal obstruction may bother another patient very 
little [36]. Children appear to have difficulty in self-assessment of symptoms and are 
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Table 3: Subjective point symptom score 
_________________________________________________________________ 
 
Point Symptom score Interpretation 
__________________________________________________________________ 
0 None:    No obstruction evident 
1 Mild:    Symptom clearly present but minimal awareness 
2 Moderate:   Definite awareness of symptom which is bothersome 
but tolerable 
3 Severe:   Symptom is hard to tolerate and interferes with 
     activities of daily life/sleeping 
 
chronically blocked nose often consider nasal obstruction “a normal condition” [57].  
2.3.2 Objective Measurement of Nasal Patency 
Although a number of procedures have been described for objective assessment of 
nasal obstruction, there is still a lack of a common consensus on a universally 
accepted method. One or more methods are often used to complement each other.  
Methods of objective measurement: 
1. Clinical examination:  
Clinical examination of the nose can be performed with anterior and posterior 
rhinoscopy and nasal endoscopy. No significant correlation has been demonstrated 
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between anterior rhinoscopy, subjective assessment or other tests. Video recording 
during flexible endoscopy is a minor invasive procedure [58]. After careful 
explanation and choice of suitable premedication (local anesthetic), endoscopy might 
be well tolerated in all instances if performed by a skilled endoscopist. 
2. Radiological examination:  
X-ray examination has been used in relation with evaluation of the paranasal sinuses 
which is increasingly being replaced by CT scan.  CT scan and MRI are non invasive 
methods that can be used to depict the anatomy of the nasal cavities. CT scan is 
useful in visualizing bony defects, but not well suited for soft tissue imaging. MRI 
however is useful in imaging mucosal structures that are important factors in nasal 
patency and volume [58]. Use of CT scan and MRI remain to be limited due to 
expense. Repeated CT scan of head imply the risk for irradiation cataract, especially 
in infants and children [59]. 
3. Rhinohygrometry:   
Rhinohygrometry, the misting of a cold shiny metal surface by warm airflow, is a 
simple inexpensive test. Modification of this traditional method has given the test a 
quantitative element in the assessment of nasal patency. However the semi-
quantitative nature of rhinohygrometry renders it flawed for serious studies [60]. 
4. Rhinostereometry:  
It is an optical direct non-invasive method for measuring nasal mucosal swelling with 
a high degree of accuracy. A surgical microscope is placed on a micrometer table. 
The apparatus is fixed to the subject with perfect alignment. The eye-piece has a 
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horizontal millimeter scale. The nasal cavity is viewed through the eyepiece. Since 
the microscope has a small depth of focus, changes in the position of the mucosal 
surface are registered in the plane of focus along the mm scale. The accuracy of the 
method is 0.2 mm [61]. The position of the head must be fixed to ensure accuracy 
during repeated measurements. This method gives only limited information of 
isolated structures and not of the larger part of the nasal airway. There are doubts 
about this method since only a few investigators have applied it and seldom has it 
been compared with other methods. Hallen and Graf [62] having compared the 
measurements of nasal mucosal swelling between AR and rhinostereometry, had 
concluded that although both the two methods were sensitive for studying nasal 
mucosal swelling there was a poor correlation between the two methods (p<0.001, 
r=0.25). 
5. Fluid displacement method:  
The nasal cavity is filled with fluid vertically from the nostril by means of a pump 
delivering constant flow. The pressure at the inlet is a measure for the height of the 
fluid, i.e., the distance into the nasal cavity. The speed of the rising surface is 
proportional to a change in pressure divided by the change in time. When the CSA of 
the cavity increases, the speed of the rising surface slows down, and vice versa. The 
fluid displacement method (FDM) is considerably accurate for measurements in small 
laboratory animals, but it can only be used post-mortem [63, 64]. 
6. Nasal casting:  
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Impression material is injected into the nasal cavity to produce casts. Casts are 
weighed to determine exact volume and sliced into segments of equal thickness for 
determination of CSA [65]. 
7. Manometric rhinometry:  
The principle is to turn the nasal cavity into a closed system and then extract a given 
volume of air from it. Any change in the volume of air within such a closed cavity 
results in a pressure change (Boyle’s Law of Gases). This pressure change can be 
measured and the original volume of the nose, sinuses and nasopharynx can be 
calculated from it. This method lacks the spatial resolution of CT scanning but can be 
used where CT examination would be inappropriate, uneconomic, impractical or 
unethical. Unlike AR or Rhm (rhinomanometry), the results are not determined 
principally by the point at which airflow rate is limited [66].  
8. Rhinomanometry:  
Rhm is a useful clinical method. Standardization of Rhm is established and accepted 
[67]. Nasal resistance of airflow is calculated from measurements of nasal airflow and 
transnasal pressure. Three types of Rhm can be used: (1) Active anterior Rhm 
(ARhm), (2) Active posterior Rhm and (3) Passive ARhm. Active ARhm is the most 
common and accurate method for clinical use [68]. The successful use of Rhm 
requires an experienced operator and significant subject co-operation in order to 
obtain reproducible and valid measurements. Rhm is time consuming and expensive 
for field application in occupational or community population studies of 
environmental exposures [69] and it cannot be performed in the presence of a septal 
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perforation or complete nasal blockage [68]. At high levels of nasal blockage, airflow 
in the nose is turbulent and leads to inconsistent readings which reduce the 
reproducibility of Rhm recordings quite considerably [70]. 
9. Rhinoresistometry:  
Analogous to Rhm, rhinoresistometry measures pressure difference and flow during 
respiration. Special software calculates additional parameters, such as: (1) flow 
resistance depending on flow; (2) degree of turbulence depending on flow; (3) 
hydraulic diameter as a parameter of width and (4) drag coefficient, describing the 
wall condition causing turbulence. The combination of rhinoresistometry and AR 
allows a better insight into structure and function of the nose. Both methods 
complement one another in their diagnostic outcome [71]. 
10. Nasal Peak Inspiratory and Expiratory Flow Meter:  
Nasal peak inspiratory flow (nPIF) has been found to be useful for objectively 
comparing nasal patency between different treatment groups in clinical settings. For 
nPIF measurement, a modified nasal continuous positive airway pressure mask is 
attached to a portable spirometer. Forced maximal inspiration measurements are 
taken. Subjects are encouraged to inhale as hard and fast as they could through the 
nasal mask [72]. Most patients need several days to practice before they become 
competent.  nPIF is as good as Rhm at assessing objective nasal patency. However 
Rhm is more sensitive in detecting the changes in nasal patency produced by exercise 
than a nPIF measurement [73]. Some authors suggest that nasal Peak expiratory flow 
(nPEF) is susceptible to technical errors. Submaximal expiration, air leakage from the 
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mouth mask and non linear nPEF apparatus can make results somewhat unreliable 
[74].  
11. Acoustic Rhinometry:   
AR measures nasal cavity dimensions with incident and reflected sound waves. This 
method is described later in detail [Figure 4]. 
2.4 ACOUSTIC RHINOMETRY 
2.4.1 Basic Principle 
An acoustic impulse is fired down a semi-infinite cylindrical tube (AR tube) into the 
object under investigation (nasal cavity). The tube has a microphone in its midsection 
and is connected to the nostril by a contoured nosepiece. Initially spark plug was used 
to generate a spark but currently continuous wide band noise is used to generate the 
acoustic signal by a digital signal processor. The sound is propagated through the tube 
and nosepiece into the nostril and undergoes partial reflection and partial transmission 
at each change in CSA along the nasal cavity, creating a reflection sequence. This 
sequence returns from the nasal cavity and travels back up the AR tube without 
further reflection. Its passage is recorded by the microphone. The reflection sequence 
is termed the input impulse response. 
Suitable algorithms enable both the reconstruction of the nasal cavity profile and the 
evaluation of its input impedance from the input impulse response [Figure 6] [76, 
77]. 
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The waves are recorded by a microphone, and digitally analyzed at the rate of 20 
times per second. The mean of 5 measurements is displayed as one curve, which is 
updated 4 times per second, ensuring dependable results. Objective measurements are 
recorded by measuring the CSA. This data is plotted as an 'area-distance function' 
which shows the CSA of the airway on the “y-axis” against distance on the “x-axis”. 
Regions of narrowing are seen as dips in the curve and widening as peaks. 
However these CSAs are not the real CSAs of the nasal cavity, but are hydraulic 
















like nasal cross-section that was measured at a certain distance from the distal part of 
the nozzle). Integration of the areas under the curve produces NV estimates [3, 77]. 
Information is saved and can be retrieved for future reference. A printout provides the 
clinicians with numeric and visual displays of the sites and magnitude of nasal airway 
lumen dimensions defined by combined structural and mucosal components. The 
mucosal components are usually investigated further by determination of the extent of 
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2.4.2 Measurements 
Several topographical measurements of the AR area- or volume-distance have been 
introduced. The following measurements are usually taken on both sides of the nasal 
cavity as described in previous studies [4, 10, 19, 78-82].  
 MCA: Minimum CSA between 1 cm and 5 cm from the nostril. Mean 
value (right and left) is calculated (mMCA).  
 d: Distance (cm) to MCA from nostril is recorded. 
 CSA-3.3: CSA at the distance of 3.3 cm from the nostril. It represents 
the anterior end of the inferior turbinate. Mean value (right and left) is 
calculated (mCSA-3.3).  
 CSA-4.0: CSA at the distance of 4.0 cm from the nostril. It represents 
the mid-portion of the inferior turbinate that has the most abundant 
erectile tissue component. Mean value (right and left) is calculated 
(mCSA-4.0). 
 CSA-6.4: CSA at the distance of 6.4 cm from the nostril. It represents 
the posterior nasal cavity. Mean value (right and left) is calculated 
(mCSA-6.4). 
 NV: NV from 1-5 cm from the nostril is often recorded. Total NV 
(tNV) is calculated as the sum of the right and left NV. Occasionally 
NV 5-10 cm from the nostril is recorded. 
Validation of acoustic rhinometry   Raza MT 
 43
2.4.3 Standardized Testing Procedure: 
Methodological aspects of measurements may vary recordings. That is why it is 
important to formulate a standardized procedure of taking measurement. A uniform 
procedure is usually followed at the Department of Otolaryngology, National 
University Hospital, Singapore. The procedure is described here.  
All AR measurement are performed using the RhinoScan module (Rhinometrics A/s. 
Lynge, Denmark). The module consists of basic system hardware (version SRE 
2100), RhinoScan software, probes and nosepieces [Figure 4]. 
All participants are first given adequate information of the procedure and advised to 
remove glasses (if any) or any nasal ornaments to avoid external pressure on the nose. 
They are acclimatized for 20 minutes prior to the test. The participants sit upright in 
an armchair, with the head properly supported and are advised to breathe through the 
mouth and hold their breath momentarily while the measurements are recorded.  
Room temperature (24-260C) and relative air humidity (45-55%) are kept constant by 
means of central air-conditioning, and background noise is kept to a minimum (less 
than 60dB). Recalibration is done if necessary. 
Each measurement is taken by an operator who has undergone training and developed 
skills under supervision. The operator is also aware of the physical limitations and 
factors influencing the reliability of AR. 
Size of nosepiece is chosen accordingly as the opening must be equal or larger than 
the opening of the nostril [83]. The same type of nosepiece is used in follow-up 
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measurements. Separate nosepieces are selected for each participant and different 
types of nosepieces are used for each nostril. The left nosepiece is marked “S” and the 
right is marked “D”.    
The probe is handheld by operators while taking measurements on all subjects. The 
nosepiece is attached to the probe and is gently pushed up to (not into) the nostril 
without distortion, while ensuring a good leak free nostril-nosepiece interface. Even 
small leaks can cause significant dissipation of the acoustic probing signal and hence 
an overestimation of nasal CSA [84].   
As soon as the nosepiece has been successfully fitted, the graph of the function of 
CSA to distance appears on the screen. Three consecutive measurements (graphs) are 
taken and the average is then calculated. The graph is saved for future reference. 
Diagrammatic representations of AR graphs in different conditions of the nose are 
illustrated in Figure 6. 
2.4.4 Advantages and Disadvantages of Acoustic Rhinometry 
Advantages 
AR is a user-friendly procedure. It is a rapid, non-invasive and easy to perform test 
and requires minimal co-operation from the patient and causes little or no discomfort 
[4, 81, 85, 86]. High reproducibility of AR makes it valuable for inter-individual 
comparisons [4, 16. 81, 86]. During measurement the patient is in apnea. As a result 
respiratory or other involuntary movements can be avoided or minimized [87]. Its 
performance is not affected by pressure and flow [85]. AR can be performed when  
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there is complete unilateral nasal blockage. ARhm cannot be performed in the 
presence of complete unilateral nasal blockage [87]. 
Disadvantages 
There is still need for a standardized technique of measurements as well as values for 
different nasal cavity dimensions. In this article we have proposed a standardized 
procedure for AR measurement. AR measurements can be recorded within seconds. 
But if standardized procedures are followed then it may be time consuming. Patients 
are required to acclimatize for 20-30minutes before taking measurements [87]. 
Nosepiece or nasal adapters can always induce nasal vestibule deformation. To 
conform to the different shapes and sizes of noses and nostrils, different nosepieces 
may be required [Figure 7][Figure 8]. AR is very sensitive to leakage. Vaseline or 
viscid water-soluble gel is often needed to seal off the nozzle ostium-externum 
interface. There are no particular characteristics in the recording generated by AR to 
alert the operator that a leak has occurred [87, 88].  
There are some physical limitations or errors associated with the algorithms used in 
AR, which are (a) sinus ostium size, sinus volume, or CSA in the distal parts  
(approximately 5-10 cm into the nasal cavity) of the nasal cavity [4, 89]. (b) a 
significant constriction in the nasal valve area will affect the CSA and NV 
measurements beyond this point [4, 90, 91] and (c) distortion of the vestibule with the 
nasal tip adapter and anatomical variations of the columella, which changes the 0 
reference points [92]. In addition to this, certain factors can affect the reliability of 
AR measurements [84] [Table 4]. 
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Figure 8: Different shapes of nostrils [6] 
 
         
 
  
    by Raza MT 
Validation of acoustic rhinometry   Raza MT 
 49




Operator   Improper connection at the nostril 
Non-reproducible positioning 
Misalignment of the probe in nasal axis 
Training and skill of the operator 
 
Subject   Variation of posture 
Improperly controlled breathing 
Sinus cavity 
Degree of accuracy from top of the septum 
Occluded or partly occluded nasal cavity 
 
Instrumentation  Calibration 
Evaluation of performance of instruments 
 
Environment   Temperature  
Humidity 
Ambient external noise 
________________________________________________________________ 
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2.4.5 Validation of Use 
Documented measurements of human airways using acoustic reflection technique was 
done more than 20 years before it was first used for the nasal cavity. Interestingly due 
to certain technical aspects, the use of acoustic reflection technique in lower airway 
measurement has decreased in contrast to the increased use for nasal cavity 
measurements. Easy accessibility, less risk of cross modes, increased clinical 
application, less sound leakage and lowered computer costs may have favored the use 
in the nasal cavity [58]. 
The different topographical measurements of the AR area- or volume-distance is 
suggested to represent a distal dimension of the nasal cavity. However as mentioned, 
there is no uniform agreement on the value and significance of each measurement in 
respect to nasal cavity dimension. MCA is the most frequently used AR determinant. 
In some subjects the MCA is located at the nasal valve while in others, especially in 
cases of turbinate hypertrophy, it is the anterior part of the inferior turbinate [58]. 
Under normal conditions, the MCA represents a narrow lumen of the functional 
valve, which is anterior (approximate 0.91 cm) to the anterior end of the inferior 
turbinate (at the distance of CSA 3.3 cm).  
Standardization of measurements, sources of error and physical limitations of AR 
measurements have not been adequately evaluated. Possible errors and physical 
limitations of AR measurement due to the natural structure of nasal cavity and 
sinuses, and constriction in the nasal valve area have been observed in laboratory 
nose models, but not in the human nose. The effects of paranasal sinuses and low-
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frequency acoustic resonances in the posterior part of the nasal cavity are not 
accounted for in the current AR algorithms [89-91].   Areas between 5 and 10 cm 
may be influenced by the sinuses and especially the ostia connecting them with the 
nasal cavity [83]. The measurement of both CSA and NV beyond a constriction area 
of less than 0.2 cm2 or 0.28 cm2 will cause significant systemic errors [90, 91].  
Phipatanakul et al. used the MCA and NV measured at 0 to 5 cm and 5 to 10 cm from 
the nostril during the acute airway response to cat allergen exposure [93]. The authors 
concluded that although AR does provide an objective measure of nasal response to 
allergen exposure, it has significant limitations due to the lack of correlation with 
symptoms, the inability to measure a dose response, and the changes noted even 
among the control subjects. However, this unexpected result could be due to the 
uncorrected volume measurements since the MCA reported was very low (<0.1 cm2) 
after cat allergen exposure. 
Acoustic rhinometry and subjective assessment  
Acoustic rhinometry and visual analogue scale 
Objective measurements of nasal patency do not always correlate with a patient's 
subjective sensation of nasal obstruction and often some people are not able to 
evaluate their nasal patency in a correct way [94]. Chan et al. [51] demonstrated no 
significant correlation between AR measurements (MCA and NV) with VAS despite 
a significant improvement of nasal obstruction in both VAS and AR measurements 
after treatment with Fluticasone propionate (FP). Roithmann et al. [95] could not 
demonstrate any significant correlation between combined (right and left) sensation 
of nasal patency (VAS) and total (right and left) MCA. However a significant 
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correlation was found between ipsilateral sensation of nasal patency (VAS) and 
ipsilateral AR measurements (MCA). The lack of association between total MCA 
with VAS may be because unilateral sensation enables subjects to better assess nasal 
airway patency.  In the evaluation of nasal patency of patients with SDs [96], AR and 
Rhm were both very sensitive in revealing deviations in the anterior nasal cavity 
(Cottle area I-II) and that correlations were found more frequently between VAS and 
Rhm than between VAS and MCA, especially for severe deviations in area I and all 
deviations in area IV (deviations between 2.5 and 4.5cm). Other studies by Kim et al. 
[97], Tomkinson and Eccles [98] and Reber et al. [99] were also unable to 
demonstrate any correlation between VAS recordings and AR measurements.  
The poor correlation between VAS and AR measurements could be due to the fact 
that VAS is actually a continuous ordinal data, whereas AR measurements are 
numerical data. As a result, small changes in the AR measurements may result in 
large shifts in the VAS. Additionally, the sensation of a nasal obstruction may not 
only be dependent on MCA and NV. It could be related to airflow patterns, the state 
of the mucociliary blanket and several other factors which can be affected by the 
underlying mucosal inflammation of rhinitis patients [51].  
Acoustic rhinometry and subjective point symptom score 
Naito et al. [47] carried out a study to compare the sensation of nasal obstruction with 
measurements by Rhm and AR in Japanese adult patients with nasal complaints. The 
sensation of nasal obstruction on bilateral breathing was divided into five ranks or a 
5-point subjective point symptom score. AR measurements were carried out by CSA 
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and NV.NV (0-4cm and 0-7cm) obtained from AR measurements correlated well 
with perception of nasal obstruction. In another study Mamikoglu et al. [100] 
demonstrated that nasal mucosal decongestion could be graded into five grades as 
mild, moderate, severe or markedly severe for objective evaluation of nasal 
congestion by AR. 
Acoustic rhinometry and other  objective methods  
Corey et al. [101] evaluated the accuracy of AR with MRI in measuring CSA and NV 
within the first 6 cm from the nostril in the pre- and post- decongested nose. The 
correlations of CSA and volume measurements between the AR and MRI were high 
in the post-decongested and low in the pre-decongested nose. This may be due to 
nasal cycle or other unknown factors. The authors concluded that AR measurements 
(CSAs and NV) provide accurate information when compared with the MRI of the 
decongested nasal airway. However while comparing AD relationships of nasal 
cavities from five decapitated dogs and cats, Straszek et al. [63] concluded that MRI 
cannot be recommended as a gold standard for validation of AR. The reason might be 
because the estimated CSA from the MRI were very much dependent on subjective 
choices in the image processing and MRI also lacks the ability to define airspaces in 
communication with the nasal cavity. It might also be due to the complexity of the 
dog and cat nasal cavity. 
AR and Rhm can provide accurate and reliable assessments of nasal patency to 
clinicians and researchers. However the two methods measure different aspects of 
nasal patency. AR measures nasal geometry calculating nasal CSA from hydraulic 
formula and Rhm measures nasal airflow and pressure. A significant, negative 
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nonlinear relationship between MCA (measured by AR) and nasal resistance to 
airflow (measured by Rhm) was demonstrated [76, 102]. The techniques can be 
complementary. AR may measure changes not measured by Rhm and vice versa.  The 
resistance of a CSA may differ considerably depending on the shape despite a 
constant area [58]. However AR measurements are direct quantification, independent 
of airflow and thus suitable for severely congested individuals. Severely blocked nose 
makes airflow turbulent and leads to inconsistent readings, which reduces the 
reproducibility of Rhm readings quite considerably. Additionally AR measurements 
are more sensitive to changes in obstruction giving AR an advantage over Rhm in 
nasal allergen challenge (NAC) studies.  On the other hand AR assessment of CSA is 
localized to a specific site, whereas Rhm measurements assess all components of the 
nasal airway [70, 102, 103].   
Straszek and Pederson [64] explored the potential of AR in pharmacological research 
of nasal passageway in guinea pigs and rats. They compared AR findings with FDM. 
For guinea pigs AR only measured 70% of the volume by FDM for the first 2 cm of 
the nasal cavity. For rats AR only measured 83% (66-100%) of volume by FDM. The 
findings suggested that absolute nasal cavity dimensions are underestimated by AR in 
guinea pigs and rats. However this does not rule out that relative changes may not be 
correctly measured. The authors suggested that FDM might be possibly the most 
accurate alternative to AR for measurements of the nasal cavity geometry in small 
laboratory animals although it can only be used postmortem. In another study 
Straszek et al. [63] compared AR measurements with MRI and FDM measurements 
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in decapitated dogs and cats and demonstrated that AR underestimated CSA 
determined by FDM especially in the deeper parts of the nasal cavity. 
2.4.6 Application 
A PubMed search (www.pubmed.com) on August 10, 2004 was carried out with 
typing “Acoustic Rhinometry”. The search yielded 402 results. The publication list 
was displayed after sorting out for “publication date”, with the latest at the beginning 
of the list. The publication at the end of the list was by Lindholdt in 1989 [104]. 
There was a total of 33 (8.2%) publications during the last one year [from August 
2003 to current]. This suggests a sustained interest in the application of AR after it 
was first mentioned 15 years back. 
AR is being widely used in research and has been used to assess the relationship 
between nasal conditioning and nasal patency and geometry, changes in the nasal 
mucosa due to sex hormones, nasal physiology in professional athletes,  effects of 
smoking on nasal patency and indoor air pollutants on nasal congestion [105-111]. 
Huang et al. [10] investigated objectively and quantitatively nasal cycle using a 
combined measurement of Rhm, AR and VAS at short intervals of 10 min, as well as 
the response of nasal cycle fluctuation to nasal decongestant on 10 adult volunteers. A 
spontaneous change in nasal geometry and resistance, but not always a reciprocal 
pattern, was observed in every consecutive measurement (10 minutes interval). A 
significant negative correlation between both nasal passages was identified in five 
subjects by Rhm and only in two subjects by AR. These cyclic changes were, 
however, not detectable after the application of nasal decongestant. The period of 
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nasal cycle is estimated at 210 minutes (range from 140-263 minutes).  The amplitude 
of daily fluctuation in MCA and NV was demonstrated to be generally less than 50% 
and for nasal resistance less than 100%, except higher values in allergic rhinitis 
subjects. In addition, even in as short as 10 minutes, the variation could be up to 14-
18% for MCA, 12-13% for NV, 47-81% for resistance during inspiration and 62-63% 
for resistance during expiration. The authors concluded that a spontaneous fluctuation 
in nasal patency could be documented by either Rhm or AR every 10 minutes with 
irregular pattern, frequency and amplitude in both healthy and allergic rhinitis 
subjects. A detectable nasal cycle is not a universal phenomenon as it is frequently 
believed.  
In another study Huang et al. [19] investigated the normal range of AR parameters in 
healthy volunteers from three racial groups in Singapore; Chinese, Malay and 
Indians. They also attempted to evaluate the role of these measurements in the 
documentation of structural abnormalities in the nose. AR measured MCA in the 
anterior 1 - 5 cm from nostril and NV between 0 to 5 cm from the nostril. The study 
demonstrated no significant difference in the normal range of AR measurements 
among the three races. AR was also able to determine the structural abnormality of 
the internal nasal cavity caused by DNS and HIT.  
AR is gradually being used in numerous clinical studies and has been used to  assess 
adenoidal tissue and the nasopharyngeal airway in children [112, 113], evaluating and 
comparing medical and surgical treatment of nasal polyps [114-117], efficacy of 
septal and turbinate surgery [71, 118-120], adenoidectomy or adenotonsillectomy 
[121, 122] and nasal septal surgery in neonates [123]. 
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Chan et al. [51] evaluated, compared and correlated the effect of FP on the symptom 
of nasal obstruction by AR and VAS. A significant improvement in the VAS post-
treatment compared to pre-treatment was noted. There was also a significant increase 
in NV and MCA after intranasal FP. Subjective improvements in symptoms did not 
correlate well with objective measurements as the correlation between VAS and AR 
was poor. The study proved AR to be a useful instrument in monitoring the 
effectiveness of medical therapy for perennial rhinitis.  
Ozturk et al. [124] assessed the efficacy of triamcinolone acetonide aqueous nasal 
spray on nasal congestion by AR. Recorded AR measurements were NV (0 to 6 cm 
from the nostril), MCA, CSA 2.1 cm and CSA 4.02 cm. For statistical purposes and 
to control the effect of the nasal cycle, the sum of right and left nasal cavity values 
were used for analysis. All AR parameters measured in all patients improved 
significantly beginning from the second week of the treatment and remained so until 
the end of the treatment in all patients. There was also substantial symptomatic 
recovery in nasal obstruction according to patients’ daily diary assessments. However 
there was no correlation between patients’ own subjective assessment of nasal 
obstruction and objective AR assessment. 
The reason behind the discrepancies between subjective assessment of nasal 
obstruction and objective AR measurements may be various, such as  variation in 
subjects relative perception and tolerance of nasal obstruction, overestimation of the 
severity of nasal obstruction and comparatively increased sensitivity of AR in 
measuring nasal patency [124].  
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3. AIM OF THESIS 
 
 
The main objectives of the present thesis are….  
“…to validate the reliability of AR in the assessment of the nasal airway and to 
establish reference values for nasal patency that can serve as a basis for further 
studies.” 
The specific aims of the individual studies were: 
• To determine standardized values and factors effecting normal nasal cavity 
dimensions in healthy individuals. (paper I and  conference poster I & II). 
Paper I: To investigate the relationship between nasal cavity geometry 
as measured by AR and body height, body weight and BMI in healthy 
adults and to determine standardized values for AR measurement. 
• To validate the use and reliability of AR and identify the limitations of AR. 
(paper II and conference oral presentation I and poster III). 
Paper II: To investigate the quantitative value and possible errors of 
various AR area-distance (AD) measurements and to assess the 
relationship between the patient’s subjective sensation and objective AR 
measurements in various nasal conditions. 
Validation of acoustic rhinometry   Raza MT 
 59
• Use of AR in clinical and research work (paper III and conference oral 
presentation II). 
Paper III: To determine if combination therapy with intranasal 
corticosteroid and oral antihistamine is superior to monotherapy in 
patients with moderate-severe PAR for symptom relief during treatment 
and prevention of relapse after cessation of therapy using subjective 
symptom score and AR. 
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4. SYNOPSIS OF THESIS 
 
 
4.1 Acoustic rhinometry measurements 
All AR measurements were done using the RhinoScan module (Rhinometrics A/S, 
Lynge, Denmark; version SRE 2100). Measurements were performed according to 
the standardized testing procedure described previously. Significance of the recorded 
measurements has already been mentioned. 
4.2 Statistical analysis 
All statistical analyses were performed using SPSS (SPSS Inc. Chicago, Illinois) 
statistical package (version 10.0) for windows. The statistical methods used will be 
described in individual studies  
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4.3 Paper 1: Relationship of body mass index, height and weight with nasal 
cavity dimensions and standardization of acoustic rhinometric values. 
4.3.1 Objective 
The nose varies with many anatomical and physiological factors. BMI, height and 
weight could also be a variable. BMI is calculated as a ratio between weight and 
height. It is a reliable indicator of body mass and fat [125].  Adults with high relative 
BMI have an increased demand for oxygen and thus may have to breathe with higher 
frequency or more larger volumes during each inspiration [5]. In addition, an 
increased relative BMI is related to increased oral and nasal pressures, as well as an 
increased nasal airflow rate. Since the higher airflow rates were clearly evidenced in 
subjects with high BMI, there might also be a correlation between BMI and nasal 
airway size and resistance to inspiratory airflow. There are only a few studies 
investigating the relationship between BMI (including height and weight) and nasal 
cavity geometry, airflow rate and resistance [5, 74, 126]. Two previous studies carried 
out in Sweden and Finland demonstrated weak or no correlation between BMI and 
nasal cavity geometry in adults [16, 74]. Such a study has not been reported in the 
Asian population, which is important in standardization of reference values for AR 
measurements.  
The objective of this study is to investigate the relationship between nasal cavity 
geometry as measured by AR and height, weight and BMI in healthy adults and to 
determine standardized values for AR measurement. 
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4.3.2 Material and methodology 
A group of 73 volunteers were selected (44 males and 29 females).  Subjects included 
were those without any nasal symptoms and no history of taking any medication for 
at least 1 month before entering the study. Individuals were excluded if there was a 
history of rhinitis/sinusitis or nasal structure malformations. BMI was calculated 
[BMI=Weight in kilograms/(Height in meters)2]. AR measurements were performed 
in the standardized procedure as previously described. 
4.3.3 Statistical analysis 
All data were expressed as mean and median with minimum and maximum values. 
Pearson and Spearman correlations were used to investigate the association between 
BMI, height and weight and AR measurements. Correlations between the different 
AR measurements were also tested. A p- value of less than 0.05 was considered 
statistically significant. 
4.3.4 Results 
All study subjects completed this study. Age range of the study population was 18 to 
64 years old with a mean (± standard error) of 34.9 ± 1.4 years. Characteristics of 
study subjects and BMI distribution is given in Table 5 and Table 6 respectively. 
There was no one in the obese class III category (BMI over 40 kg/m2). Values of 
different AR measurements are given in Table 7. There is a significant correlation 
(p<0.001) among all AR measurements. Measurements of BMI, height, weight 
showed no statistically significant correlation with any AR measurements. Scatter 
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plots showing distribution of height, weight and BMI in relation to MCA in the study 
population have been demonstrated in Figure 9, Figure 10 and Figure 11 
respectively. 
4.3.5 Discussion 
The standardization for AR measurements in the “normal nose” as compared to 
different types of structural and mucosal abnormalities is important. A strict selection 
criteria was abided to select study subjects with healthy noses and a standardized 
procedure was followed to perform AR measurements. MCA is the most frequently 
used AR determinant. The mMCA was (0.74 ± 0.03 cm2). This value correlated well 
with values of a previous study (0.75 ± 0.02 cm2) that was performed in healthy adult 
Singaporean Chinese, Malays and Indians [19] in the same center. The same study 
also had demonstrated that there was no significant difference of AR measurements in 
these three races. Thus the AR measurements obtained could be used as a 
standardized normal value for the population of Singapore. 
According to our study nasal cavity size did not change with increasing BMI. 
Whether this lack of correlation has any role on illnesses associated with increased 
BMI could be a matter of interest. The mean BMI of the study population was 23.1 
kg/m2 (median of 22.7 kg/m2), which is close to an adult ideal BMI as recommended 
by WHO (World Health Organization) [127]. The age, weight, height and BMI 
distribution corresponded well with a cross-sectional population study carried out on 
4723 adult Singaporeans [128]. It indicates that the study population 
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Table 5: Characteristics of study subjects in paper 1 
_____________________________________________________________________ 
  Mean ± SD Median Minimum Maximum 
 
_____________________________________________________________________ 
Female      
 Age (yr) 36.6 ±10.9 37 18  59 
 Weight (kg) 57.9 ± 11.8 55.0  38.0 88.0 
 Height (m) 1.57 ± 6.4 1.56  1.44 1.67 
 BMI* (kg/m2) 23.9 ± 4.9 22.7  15.6  37.6  
Male      
 Age (yr) 33.5 ± 11.7 30  22  64  
 Weight (kg) 66.9 ± 9.3 65.5  38.0 86.0  
 Height (m) 1.71 ± 7.3 1.72  1.50  1.88  
 BMI* (kg/m2) 22.7 ± 3.3 22.7  13.2 30.5  
_____________________________________________________________________ 
*BMI, Body mass index 
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Table 6: Body mass index distribution of the population in paper 1 
_____________________________________________________________________ 
BMI* (kg/m2) WHO** Study (n)  
 classification 
_____________________________________________________________________ 
< 18.5 Underweight 4 
18.5-24.99 Normal range 50 
≥ 25.00 Overweight 19 
25.0-29.9 Preobese 15 
30.0-34.99 Obese class I 3 
35.0-39.9 Obese class II 1 
≥ 40.0 Obese Class III 0 
_____________________________________________________________________ 
* BMI, Body mass index 
** WHO, World Health Organization [127] 
 
Validation of acoustic rhinometry   Raza MT 
 66
Table 7: Acoustic rhinometric measurements in paper 1 
_____________________________________________________________________ 
 Right ± SE Left ± SE Mean ± SE Total ± SE 
_____________________________________________________________________ 
CSA-3.3 (cm2)  1.24 ± 0.07 1.30 ± 0.06 na na 
CSA-4.0 (cm2) 1.76 ± 0.12 1.68 ± 0.08 na na 
MCA (cm2) 0.74 ± 0.04 0.74 ± 0.03 0.74 ± 0.03 na 
V (cm3) 5.69 ± 0.20 5.60 ± 0.17 na 11.3 ± 0.3 
_____________________________________________________________________ 
CSA, Cross sectional area 
MCA, Minimum cross sectional area  
V, Volume of nasal cavity 1 to 5cm from the nostril. 
NA, not applicable 


















Figure 9: Distribution of minimal cross sectional area values in relation to  
height (cm) of study population in paper 1 



















Figure 10: Distribution of minimal cross sectional area values in relation to  
weight (kg) of study population in paper 1.  

















Figure 11: Distribution of minimal cross sectional area values in relation to  
Body mass index (kg/m2) of study population in paper 1 
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was representative of the Singaporean population.  However we did not have any 
patients in our study with morbid obesity (Obesity class III, BMI > 40 kg/m2) [127]. 
Further studies to illustrate the effect of a very high BMI on nasal cavity geometry 
and respiratory physiology are needed. 
Nasal decongestants can change the normal mucosal turgidity, thereby invalidating 
the measurements as indicators of normal anatomical and physiological status in 
healthy noses [74].  The high mucosal blood volume and increased vascular tissue 
lining in the bony turbinates has effect on nasal cavity physiology, like nasal wall 
compliance [129]. Nasal wall compliance increases progressively from the nasal 
valve to the anterior and medial part of the inferior turbinate and to the middle meatus 
region (although the turbinates are located within a non distensible bony cavity). 
After decongestant, compliance decreases and became similar in these three regions. 
Acclimatization period reduces mucosal variability during measurement All subjects 
were acclimatized for 20 minutes prior to the test [58].  There is still a lack of a 
standardized method of use of decongestants in clinical and research purposes. 
Efficacy of decongestants differs on route of administration, type of preparation, time 
duration after administration and method of application. In the non-decongested nose 
a significant difference in mMCA has been demonstrated between three racial groups 
(Oriental, Caucasians and Negroes). After application of a decongestant, Orientals 
and Caucasians become a homogenous population with the value for Negroes 
remaining significantly higher. This would suggest that much of the difference in 
MCA seen between Orientals and Caucasian was due to an increased amount of 
vascular tissue in Orientals. The fact that this remained significantly higher in 
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Negroes after decongestion would suggest that they have a larger bony aperture. Thus 
the findings of apparent HIT on anterior rhinoscopy in Negroes may be the normal 
state [18].  Therefore, we did not use decongestants as did two similar studies carried 
on the European population [16, 74].  
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4.4 Paper 2: Clinical value of acoustic rhinometry measurements, and the 
relationship between subjective sensation and objective acoustic 
rhinometry measurements 
4.4.1 Objective 
All possible sources of errors and physical limitations have to be considered when 
using AR as an investigational tool in study of nasal physiology and pathophysiology 
in various clinical and experimental settings. Standardization of measurements, 
sources of error and physical limitations of AR measurements have not been 
adequately evaluated. In addition, erectile tissue in the nose, especially the inferior 
turbinates, fluctuates greatly in size depending on physiological changes (e.g., nasal 
cycle, body temperature, posture and exercise) and response to inflammation [10]. All 
these factors have to be taken into account when using AR as an investigational tool 
in different studies. 
The main objective of this paper is to investigate the quantitative value and possible 
errors of various AD measurements of AR and to assess the relationship between the 
patient’s subjective sensation and objective AR measurements in various nasal 
conditions. 
4.4.2 Material and Method 
Fifteen adult patients (8 males and 7 females) between 21 and 44 years of age (mean 
age of 28.4 years) with ongoing PAR were recruited. The patients had no acute nasal 
symptoms and had not taken any medication during the previous two weeks (at least 
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30 days for any nasal or systemic corticosteriods). Their sensitization to Bt (blomia 
tropicalis) was confirmed by a positive skin prick reaction. Crude extract of Bt was 
prepared from cultured mites, as described previously [130].  
Nasal obstruction was recorded using a 4 point symptom score [Table 3]. AR 
measurements were performed in the standardized procedure as previously described. 
Nasal allergen challenge 
The NAC was carried out in a double-blind manner using nasal spray, 1 puff (0.04 ml 
of allergen solution) per nostril. The study subject was asked to be in complete apnea 
during spraying. This precaution would prevent the provocation extract from entering 
the lower airway. The NAC was started by using phosphate-buffered saline (PBS) 
(diluent of allergen extract) and then subsequently increasing concentrations of Bt 
extracts; 0.6 µg/ml (low), 6 µg/ml (medium) and 60 µg/ml (high) at intervals of 15 
min. Subjective and objective symptoms were collected as a baseline, 15 minutes 
after each nasal challenge and at 30 min, 1, 3, 5 and 7 hours after the last challenge in 
order to study the early-phase reaction (EPR) and late-phase reaction (LPR). After a 
washout period of at least 2 weeks, 6 of the patients underwent an identical 
challenging procedure with only PBS as a control. 
4.4.3 Statistical analysis 
A repeated measurement analysis was performed to assess the time-trend of the 
responses and mean differences between the mite-challenge subjects and controls 
taking into account the group & time interactions. Coefficient of variation (CV) was 
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used to compare the variability of the AD measurements at each CSA area over time. 
Spearman’s correlation was applied to investigate the relationship between AD 
measurements of AR and subjective symptom scores. 
4.4.4 Results 
All study subjects completed the study.  
Subjective nasal symptoms 
Figure 12 shows the mean nasal (±SD) symptom scores before and after NAC with 
control solution (PBS) and Bt. There was a dose-response increase in nasal 
obstruction score after Bt challenges with a maximal blockage (mean score of 
2.33±0.25) at 30 min after challenge. There was a significant difference (p=0.025) 
between the two groups with the study-subjects experiencing a significant change 
over time (p=0.011) but not the controls (time & group interactions, p=0.002).  
AR area-distance measurements 
Figure 13 shows the mean (±SD) of MCA, distance to MCA, CSA 3.3, CSA 4.0 and 
CSA 6.4 measurements at different time points after nasal challenge with Bt and 
control solution. For mMCA, mCSA 3.3 and mCSA 4.0, reduction of CSAs after 
nasal challenges with Bt are confirmed by statistically significant differences as 
compared to control challenge, as well as time trend and time group interactions. 
Maximal reduction of mMCA (0.26 cm2) is associated with the maximal increase of 
mean distance to MCA (2.86 cm) at 30 min after NAC.  
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CV at different CSAs is shown in Table 8. The variation at mCSA 6.4 is more varied 
as compared to the other AD measurements as shown by the larger mean CV with a 
twice as large standard error and wider range (minimal and maximal values).  
Relationship between nasal symptom scores and AR area-distances 
There is an inverse relationship between symptoms score and MCA (r=-0.568, 
p<0.001) [Figure 14]. Although there are significant correlations between nasal 
obstruction scores and all 4 area-distance measurements, it appears that the strongest 
relationship is found between nasal symptom score and mMCA (r = 0.75), and 
followed by mCSA 3.3 (r = 0.54), mCSA 4.0 (r = 0.53) and mCSA 6.4 (r = 0.20). In 
the correlation between MCA and the other 3 AD measurements, once again the CSA 
6.4 measurement differs largely from other AD measurements in terms of their 
relationship with nasal obstruction score and MCA. 
Influence of constriction of MCA (<0.2 cm2) on area-distances beyond MCA 
Results showed that when the MCA reached an area <0.2 cm2, measurements of CSA 
3.3 and CSA 4.0 were reduced by 60 – 70%. 
 
 







Figure 12: Mean subjective symptom score of nasal obstruction before and after 




















Differences between case and control: p = 0.025 
Time trend: p = 0.011 
Time & group interaction: p = 0.002.  
Baseline Control Low Medium High 30 minutes 1 hour 3 hours 5 hours 7 hours 
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Figure 13: Mean values (±SD) of MCA, CSA 3.3, CSA4.0 and CSA 6.4 after 
nasal challenge with house dust mite Blomia tropicalis (Bt) and control solution 
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Table 8: Coefficient of variation at different cross sectional areas (cm2) in study 2.  
Calculations were based on a total of 420 measurements; nasal challenges with 
Blomia tropicalis (n=15) and control solution (n=6) at 10 different time of 
measurements, right and left sides [2]. 
____________________________________________________________________ 
Area in Coefficient of variation 
Distance  ___________________________________________________ 
(cm)  
 Mean Standard  Minimum Maximum Median 
   error   
____________________________________________________________________ 
 
MCA* 0.47 0.06 0.23  0.76 0.45 
CSA 3.3  0.52 0.06 0.28 0.82 0.47 
CSA 4.0  0.42 0.05 0.24 0.64 0.39 
CSA 6.4 0.61 0.11 0.35 1.45 0.46 
____________________________________________________________________ 
p = 0.533 (kruskal wallis test). 
*: Minimum cross-sectional area. 
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Figure 14: Correlation between MCA and symptom score in paper 2. Spearman’s 
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4.4.5 Discussion 
AR area-distance measurements 
Beside MCA the other common AR measurements are CSA at a distance of 3.3, 4.0 
and 6.4 cm from the nostril. However MCA appears to be the most sensitive 
measurement. In study 2 we demonstrated that CSA 6.4 was found to be least 
reliable. It was reported that the effects of paranasal sinuses and low-frequency 
acoustic resonances in the posterior part of the nasal cavity are not accounted for in 
the current AR algorithms [89]. Areas between 5 and 10 cm may be influenced by the 
sinuses and especially the ostia connecting them with the nasal cavity [83]. 
In some subjects the MCA is located at the nasal valve while in others, especially in 
cases of turbinate hypertrophy, it is the anterior part of the inferior turbinate [68]. 
Under normal conditions, the MCA represents a narrow lumen of the functional 
valve, which is anterior (approximate 0.91 cm) to the anterior end of the inferior 
turbinate (at the distance of CSA 3.3 cm). During allergic reactions, it moves more 
posteriorly to the anterior end of the inferior turbinate due to the dilative reaction of 
the capacitance vessels of the erectile tissue.  In paper 2 the mMCA moved 
posteriorly from a baseline distance of 2.39 ± 0.16 cm to a distance of 2.86 ± 0.31 cm, 
thirty minutes after NAC. 
Measurements beyond a significant constriction 
It has been demonstrated with models that CSA and volume beyond a constriction 
area of less than 0.2 cm2 or 0.28 cm2 will cause significant systemic errors [90, 91]. In 
Validation of acoustic rhinometry   Raza MT 
 81
normal adults the CSA of the nasal valve is 0.2-0.6 cm2. As the constriction narrows 
(<0.2 cm2) the measurements beyond this point are often underestimated [91]. 
MCA (left and right separately) was divided into two groups; <0.2 cm2 and ≥0.2 cm2 
as measured during the time course of NAC, and then compared with the 
corresponding AD measurements (CSA 3.3, CSA 4.0 and CSA 6.4) beyond the 
MCA. Results showed that when the MCA reached an area <0.2 cm2, measurements 
of CSA 3.3 and CSA 4.0 were reduced by 60 – 70%. This is particularly important 
when using AR in a nasal challenge study, which may cause severe nasal obstruction 
during the EPR.  
Subjective measurements 
There is an inverse relationship between subjective symptoms score and MCA (r=-
0.568, p<0.001). With subjective symptom scores of zero and one, there was a wider 
range of MCA which corresponded well with a wide variation of normal nasal cavity 
dimensions. Interestingly, MCA range is more specific with pathological conditions 
causing severe nasal obstruction (score 2 and 3). 
Although there are significant correlations between nasal obstruction scores and all 4 
area-distance measurements, it appears that the strongest relationship is found 
between nasal symptom score and mMCA (r = 0.75), and followed by mCSA 3.3 (r = 
0.54), mCSA 4.0 (r = 0.53) and mCSA 6.4 (r = 0.20). The correlations between MCA 
and the other 3 area-distance measurements are shown in [Table 9]. CSA 6.4 
measurement differed largely from other AD measurements in terms of their 
relationship with nasal obstruction score. 
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Table 9: Interrelationships of acoustic rhinometry area-distance measurements, and 
their relationship with the subjective nasal obstruction scores in paper 2 [2]    
 ______________________________________________________________ 
Area in Coefficient Correlation 
Distance (cm) ____________________________________________ 
 
 MCA Nasal Obstruction Scores 
______________________________________________________________ 
MCA* - 0.75 (p<0.001) 
 
CSA** 3.3  0.807 (p<0.001) 0.54 (p<0.001) 
  
CSA 4.0  0.631 (p<0.001) 0.53 (p<0.001) 
 
CSA 6.4 0.359 (p<0.001) 0.20 (p<0.001)  
______________________________________________________________ 
*MCA : Minimum cross-sectional area. 
**CSA: Cross-sectional area 
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4.5 Paper 3: Comparison between combination therapy (intranasal 
corticosteroid and oral antihistamine) and monotherapy in perennial 
allergic rhinitis patients 
4.5.1 Objective 
The clinical application of AR has gradually increased. Numerous studies have been 
carried out with the aid of AR to evaluate and compare the efficacy of different 
medical and surgical modalities of treatment.   
Allergic rhinitis may significantly impair the quality of life (QOL), limit daily 
activities and affect the performance and productivity of those affected. Nasal 
obstruction is the most common symptom of PAR [41]. To be effective in treating 
allergic rhinitis, any modality of treatment should be able to reduce nasal obstruction. 
AR can be used to measure objectively the efficacy of reducing nasal obstruction. 
Both intranasal corticosteroids (INC) and antihistamines have been shown to be 
effective for allergic rhinitis. In patients with persistent disease, it is often difficult to 
ensure compliance for longer periods despite the continued presence of symptoms. 
Hence short term intermittent therapy could be more acceptable and practical. Such a 
therapeutic strategy has not been explored previously and the efficacy of INC and 
antihistamines, whether used singly or in combination in such a strategy has not been 
widely studied. 
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The objective of this study is to determine if combination therapy with INC and oral 
antihistamine is superior to monotherapy in patients with moderate-severe PAR for 
symptom relief during treatment and prevention of relapse after cessation of therapy. 
4.5.2 Material and Methodology 
Forty-two patients with moderate-severe PAR were randomized into 3 treatment 
groups to receive intranasal triamcinolone acetonate (TAA), fexofenadine or a 
combination of both for 4 weeks. Patients were assessed during the initial 
randomization visit and at the end of the 4-week treatment period. Treatment was 
terminated after 4 weeks unless special requests were made for continuation. 
Outcome measures recorded and analysed at initial and follow-up assessments 
included both subjective and objective parameters.  
A 4- point scale was used to assess nasal symptoms (obstruction, itch, sneezing and 
rhinorrhoea) separately. The individual scores were added to get the total symptom 
score. Efficacy measures were changes from baseline in nasal symptom scores (both 
individual and total scores), disease severity, Rhinoconjunctivities QOL questionnaire 
scores (RQLQ), AR measurements (mCSA 3.3cm and tNV 1 to 4cm from nostril) and 
patient-rated overall treatment efficacy at the end of therapy. AR measurement were 
recorded using the standardized testing procedure as previously described. 
4.5.3 Statistical analysis 
Postulating that a unit decrease from baseline in week 4 for each symptom score 
within treatment groups is of clinical significance, with a standard deviation of 1 for 
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the difference between week 4 and baseline, 14 subjects in each group were required 
to obtain a statistical significance basing on a 2-sided test of 5% and power 80%. 
Data were expressed as values and percentages or as mean ± standard deviation 
where applicable. Analysis was performed using the Chi-square test (with Fisher’s 
correction if necessary) for categorical variables with odds ratios presented where 
applicable. One-way analysis of variance (ANOVA) for continuous variables were 
performed when normality and homogeneity of variance assumptions were satisfied 
otherwise the Kruskal-Wallis test was applied. A p value of <0.05 was considered 
statistically significant. 
4.5.4 Results 
At week 4, the mean individual and total nasal symptom scores in all the 3 treatment 
groups were reduced and the improvement was significant compared to baseline. The 
combination group achieved better improvement than the monotherapy groups though 
inter group difference was not statistically significant.  
Like nasal symptom score there was no significant difference between the groups in 
the mean change from baseline of the mCSA and tNV [Table 10]. However objective 
AR measurements at week 4, showed significant improvement in mCSA and tNV 
from baseline only in combination and TAA groups indicating improved nasal 
patency. No improvement was demonstrated in the fexofenadine group. Likewise 
patients in combination and TAA groups were more likely to rate their therapy as 
effective. (OR=8. 95% CI 1.8 - 35.7) 
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Compared to monotherapy, patients on combination therapy reported a significant 
improvement in quality of life (decrease in overall RQLQ score 2.14±1.34 vs 
1.13±0.78 and 1.15±1.02 for combination vs nasal corticosteriod and antihistamine 
respectively) and reduction in disease severity (71.4% vs 50% and 21.4% respectively 
improved to mild PAR) during the treatment period. A high relapse rate (>70%) was 
observed in all groups after cessation of therapy. 
4.5.5 Discussion 
One-month combination therapy was not superior to monotherapy over the same 
duration for symptom relief or AR measurements f nasal patency.  However 
combination therapy was associated with significant improvement in the patients’ 
QOL and in reducing the disease severity compared to monotherapy. The disease 
control at the end of the treatment period was suboptimal and the relapse rate one 
month after cessation of therapy was high in all three groups. 
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Table 10: Mean acoustic rhinometry measurements: at baseline, week 4 and change 
from baseline at week 4 in study 3. 
_____________________________________________________________________ 
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“Acoustic rhinometry is a user-friendly procedure suitable for clinic and 
research. It is a rapid, non-invasive and easy to perform test that requires 
minimal co-operation from the patient causing little or no discomfort and is 
highly reproducible. ” 
 
1. Acoustic rhinometry is a useful and objective investigational tool in the 
evaluation of nasal physiology and pathophysiology. 
2. Several topographical acoustic rhinometry measurements of the area- or 
volume- distance have been introduced. We have demonstrated minimal cross-
sectional area (MCA) to be the most sensitive parameter that correlates well 
with the sensation of nasal obstruction. Meanwhile cross sectional area 
measurements at 6.4 cm from the nostrils were found to be least reliable.  
3. Possible errors and physical limitations of acoustic rhinometry measurements 
have been observed in laboratory nose models. We have demonstrated in 
humans that distal measurements beyond a significant constriction (MCA ≤ 0.2 
cm2) can be underestimated and should be ignored.  
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4. Methodological aspects of measurements can influence acoustic measurements. 
A standardized procedure of recording measurement has been described in 
detail in the thesis. 
5. Acoustic rhinometry can be used successfully in clinic and research. We have 
defined the value for the normal nasal cavity dimensions for healthy 
Singaporean adults (mMCA was 0.74 ± 0.03 cm2). By acoustic rhiometry 
measurements we also concluded that nasal cavity geometry is not affected by 
body mass index, body height and weight.  
6. Acoustic rhinometry measurements of nasal airway patency helped to evaluate 
different treamtent therapies for allergic rhinitis.  
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6. FUTURE RESEARCH 
 
 
• There were no subjects in our study (paper 1) with morbid obesity (Obesity 
class III, BMI > 40 kg/m2). Further studies to illustrate the effect of a very high 
BMI on nasal cavity geometry and respiratory physiology are needed. 
• A reference AR values for normal nasal cavity dimensions in children of our 
population (Singaporean) is also required which will help to understand 
pathogenesis of certain disease processes, as for example OSA and otitis media. 
• The relationship between subjective sensation and objective acoustic 
rhinometry measurements has been seen in a NAC study (paper 2). Such 
relationship should be investigated in non-challenge patients. 
• Standardized testing procedure is required to be compared with other 
procedures followed in other institutions for possible errors. 
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7. ADDITIONAL RESEARCH 
 
 
7.1. Control of nasal obstruction in perennial allergic rhinitis. 
Nasal obstruction, the cardinal symptom of PAR, is one of the most common 
symptoms encountered in primary care and in specialist clinics. It is difficult to 
quantify by clinical examination, and, hence, objective assessment of the nasal airway 
is critical to rhinologic research. Nasal obstruction in PAR must be treated the year 
round, and therefore treatment choices, costs, and compliance all become important 
public health issues. 
Many inflammatory and neurogenic mediators released during allergic reactions are 
able to cause plasma exudation and vasodilatation, with resultant edema and swelling 
of the nasal mucosa. Recently, technological advancements have made it possible to 
qualitatively and quantitatively study the nasal airway, providing greater insights into 
the understanding of physiological fluctuation and pathophysiological manifestations 
of nasal patency. From recent international guidelines, the management of allergic 
rhinitis includes combining treatments of the upper and lower airways, by using 
patient education, allergen avoidance, pharmacological treatment, and specific 
immunotherapy. Surgery may be needed as an adjunctive intervention. Multiple 
methods have been introduced to treat turbinate hypertrophy. However, preservation 
of adequate nasal mucosal function is important, together with long-term results.  
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It is important that consensus recommendations for the management of allergic 
rhinitis be designed and implemented by all levels of medical specialists in order to 
improve treatment outcomes. 
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7.2. Biological Characteristic Of Histamine And Its Role In Allergic Rhintis 
Histamine is a major mediator and antihistamines are among the most commonly 
used pharmacologic treatment of allergic disorders. Histamine stimulation of the 
nasal mucosa produces the classical symptoms of allergic rhinitis.  Histamine exerts 
its actions through interaction with four recognized human histamine-receptor 
subtypes (H1-4).  The role of histamine in nasal symptomatology is confirmed by the 
reproduction of nasal symptoms after nasal provocation with histamine and that these 
symptoms can be inhibited by the application of histamine receptor antagonists  
Effects on the human nose may be mediated via both H1R and H2R and the role of 
H3R has not been fully clarified. H1R stimulation reproduces any of the classical 
symptoms of rhinitis and therefore can be well controlled by H1-antihistamines, with 
the greatest effect on the neurally mediated responses. The vast majority of H1R on 
nasal mucosal blood vessels are localized on endothelial cells and stimulation of the 
HIR induces vascular permeability in the nasal mucosa. The role of H2R in capillary 
permeability is uncertain. The dilatation of nasal capacitance vessels responsible for 
the increase in nasal airway resistance is mediated via both H1R and H2R, but the 
effect of the H2R predominates. Vasodilation mediated by H1R is rapid in onset but 
short lived and that by H2R is slower in onset but more sustained. Therefore a 
combination of H1R and H2R antagonists are more effective than H1R blockers alone 
in reducing nasal congestion.  
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7.3. Association of Rhinitis with Atopy, Asthma, Hypertension and Some 
major illness 
The aim of this study was to investigate the relationship between rhinitis, PAR, 
asthma and major illness (e.g., hypertension, coronary arterial disease, diabetics) in 
Singapore. A significant association between rhinitis and atopy, asthma, high density 
lipoprotein-cholesterol and age was found. In patients with PAR, significant 
associations were found between PAR and asthma, age, coronary arterial disease, 
diabetes(negative) and BMI (negative). Asthma was only associated with rhinitis and 
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9.1 Paper 2: Clinical value of acoustic rhinometry measurements, and the 
relationship between subjective sensation and objective acoustic rhinometry 
measurements  
(published) 
Wang DY, Raza MT, Goh YT, Lee BW, Chan YH. Acoustic rhinometry in nasal 
allergen challenge study: which dimensional measures are meaningful? Clin Exp 
Allergy 2004;34:1093-1098 
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9.2 Paper 6: Review of the pathology and management of nasal obstruction. 
(published) 
Wang DY, Raza MT, Gordon BR.. Control of nasal obstruction in perennial allergic 
rhinitis. Curr Opin Allergy Clin Immunol. 2004 Jun;4(3):165-170. 
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9.3. Oral 1: Acoustic rhinometry in nasal allergen challenge study: 
which dimensional measures are meaningful? 
(presenting author) 
Wang DY, Raza MT, Goh YT, Lee BW, Chan YH. 
The 5th Combined Scientific Meeting incorporating The 4th GSS-FOM Scientific 
Meeting, 12-14 May 2004, Clinical Research Centre, National University Singapore, 
Singapore. 
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9.4   Poster 1: “Correlation Of Body Mass Index, Height And Weight With 
Nasal Cavity Geometry In Adult Singaporeans” (presenting author) 
Raza MT, Wang DY 
4th Combined Scientific Meeting, Incorporating Second Singapore Microarray 
Meeting. 15-18 January 2003, Clinical Research Centre, National University of 
Singapore 
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9 
CORRELATION OF BODY MASS INDEX, HEIGHT AND WEIGHT 
WITH NASAL CAVITY GEOMETRY IN ADULT SINGAPOREANS
RAZA Md. Tanveer, WANG De-Yun
Department of Otolaryngology, Faculty of Medicine, National University of Singapore
Background
A patent nasal passage is important. Nasal airflow rate and oral and nasal pressure increase 
with increasing BMI. This study aims to determine if with increased BMI, the nasal cavity 
geometry increases in healthy Singaporean Chinese, Malays and Indians
Acoustic Rhinometry (AR)
Sends sound waves into nose. Incident and 
reflected waves are recorded by
Minimally invasive, rapid, convenient and accurate
microphone. In seconds the cross sectional areas and 
volumes is measured and a two dimensional graphic 































Deviated Nasal Septum (Lt)
Rhinological Examination
General Anatomy: Normal
Septum: Deviation To Left Side
Measured Indices of the nasal Cavity
Nasal Volume of the first 5 cm from the nostrilNV-5
Minimum Cross Sectional AreaMCA
Cross Sectional Area at the distance of 4.0 cm from nostrilCSA-4.0
Cross Sectional Area at the distance of 3.3 cm from nostrilCSA-3.3
BODY MASS INDEX
Metric Formula
BMI =Weight in kilograms ÷ 
[Height in meters]2 or
BMI = [Weight in kilograms ÷ 
Height in cm ÷ Height in cm] x 
10,000
English Formula
BMI = [Weight in pounds ÷ 
Height in inches ÷ Height in 
inches] x 703 
Are You Obese?
Underweight <18.5 kg/m2
Normal weight  18.5-24.9 kg/m2
Overweight  25-29.9 kg/m2
Obesity  30 kg/m2 or greater
Body Mass Index
Research Questions
In the Adult Singaporean population is there a relationship 





Height and weight measured
BMI calculated
MCA , CSA-3.3, CSA-4 & NV-5 
computed
In a national rhinitis survey study, 268 adult volunteers were 
called to attend a rhinologic examination in the ENT Clinic of 
NUH. Individuals were then excluded with the existence of any 







































































































































































Correlation is significant at the 0.01 level (2-tailed).
Results
Although there is correlation of height 
and right distance of MCA no 
significant correlation was noted on 
left side. This requires further study
Conclusions
BMI and Nasal Cavity Geometry        No 
relationship
Height and Nasal Cavity Geometry No 
relationship
Weight and Nasal Cavity Geometry       No 
relationship
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9.5 Poster 2: Acoustic rhinometry in nasal allergen challenge study which 
dimensional measures are meaningful? (presenting author) 
Wang DY, Raza MT, Goh YT, Lee BW, Chan YH.Height And Weight? 
5th International Symposium on Experimental Rhinology and Immunology of the 
Nose, November 17-19, 2003. Ghent-Belgium. 
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Acoustic rhinometry in nasal allergen challenge study: which dimensional 
measures are meaningful?
1WANG De Yun, 1RAZA Md Tanveer, 2GOH Yam Thiam, 2LEE Bee Wah, 3CHAN Yiong Huak. 
Departments of Otolaryngology1 and Paediatrics2, Faculty of Medicine, The National University of Singapore. 3Clinical Trial & Epidemiology Research Unit, Singapore
Fig 4: Correlation between MCA and symptom score. Spearman’s correlation: 
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Acoustic rhinometry (AR) is commonly used in quantitative assessment 
of nasal response to nasal allergen challenge (NAC). Sources of error 
and physical limitations of various AR area-distance measurements are 
not fully understood
OBJECTIVE
¾Clinical value of AR measurements and 
¾Relationship between objective AR 
measurements & subjective sensation of nasal 
obstruction in NAC study.
METHODS
Study patients
¾15 Adults (8 Males & 7 Females) with ongoing Perennial Allergic Rhinitis 
(PAR). 
¾Age: 21 to 44 years (mean 28.4 years). 
¾Sensitization to Blomia tropicalis (Bt) (confirmed by positive skin prick 
reaction). 
¾No acute nasal symptoms & history of taking medication during the last 2 
weeks (at least 30days for any nasal and/or systemic corticosteriods) 
NAC
¾Nasal spray, 1 puff (0.04 ml of allergen solution)/nostril (Complete apnea 
prevents entry into lower airway) 
¾NAC started by using PBS (diluent of allergen extract) 
¾Then subsequently increasing concentrations of Bt extracts; 0.6 µg/ml 
(low), 6 µg/ml (medium) and 60 µg/ml (high) at intervals of 15 min. 
¾Symptom score collected as a baseline,15 min after each challenge and 30 
min, 1 , 3 , 5 & 7 hours after last challenge to study the early-and late-phase 
reactions. 




¾0=None (No evidence) 




¾3=Severe (Hard to tolerate, causing 
interference with activities of daily 
life/sleeping)
Objective: AR
¾Standard procedure as described in 
previous reports [1]
¾Measured Cross-sectional area (CSA) from 
the nostril:
•MCA: minimum CSA between 1 to 5 cm.
•Distance (cm) to MCA.
•CSA 3.3: 3.3 cm (anterior end of inferior 
turbinate) [2]
•CSA 4.0: 4.0 cm. (mid-portion of the 
inferior turbinate) 
•CSA 6.4: 6.4 cm. (posterior nasal cavity) 
¾Mean (right and left) values were 
calculated.
Physical limitations
1. CSA in the distal parts of 
the nasal cavity
(approximately 5-10 cm into 
the nasal cavity)
a. Sinus ostium size
b. Sinus volume
2. Measurements beyond a 
significant Constriction 
(CSA < 0.2cm2 ) [4]
3. Reference point changes.
• Distortion of the vestibule with 
nasal tip adapter
• Anatomical variations of 
columella
MCA <0.2 cm2 MCA≥0.2 cm2
Distance-area (cm2) Distance-area (cm2)
______________________ ______________________
n   CSA3.3  CSA4.0  CSA6.4 n    CSA3.3  CSA4.0  CSA6.4
______________________________________________________________
Baseline 0     - - - 30     - - -
Control 0     - - - 30     - - -
Low† 1     0.08 0.13 2.21 29    1.02        1.55       2.87
Middle† 6     0.25*      0.58*      2.05 24    0.83        1.23 2.11
High† 15   0.26**    0.6**      3.64*        15    0.85        1.18 1.86
30 min 13   0.19**    0.52**    2.34*        17    0.64 1.02 1.86
1 hr 11   0.35**    0.37**    0.78**      19    0.92 1.13 1.80
3 hrs 4     0.25**    0.57* 1.02*         26   1.02 1.59 2.48
5 hrs 5     0.35*      0.76* 1.47 25   0.93 1.42 2.39
7 hrs 5     0.25**    0.67**   1.23*          25  1.03 1.56 2.82
______________________________________________________________






n=30) < 0.2 
cm2 at different 
measurement 




of CSA 3.3, 4.0 
& 6.4 cm 
beyond this 
point.
Fig 3. Mean subjective symptom 
score of nasal obstruction before and 
















































Differences between case and control: p = 0.025
Time trend: p = 0.011
Time & group interaction: p = 0.002.
RESULTS
¾Dose-response increase in nasal obstruction score was significantly 
(p<0.001 for all) associated with decreases in mean MCA  and the three 
measured mean CSA’s.
¾When MCA (left and right separately) reached an area <0.2 cm2, 
measurements of CSA 3.3, 4.0 and 6.4 were significantly reduced.
CONCLUSION
AR proved to be a useful and objective investigational tool in evaluating 
nasal physiology and pathophysiology. MCA appears to be the most
sensitive and correlates well with the sensation of nasal obstruction. 
When MCA is smaller than 0.2 cm2, other distal measurements beyond 
this point can be underestimated and should be ignored. 
MCA CSA 3.3 CSA 4.0 CSA 6.4
Nasal Obstruction 0.75 0.54 0.53 0.2
Coefficient Correlation
Table 3: Interrelationships (p < 0.001) 
between different AR measurements
Coefficient Correlation
CSA 3.3 CSA 4.0 CSA 6.4
MCA* 0.807 0.631 0.359
Table 2: Interrelationships (p 
< 0.001) between AR 
measurements & subjective 
nasal obstruction scores
¾CSA6.4 measurement 
differs largely from other 
area measurements in 
terms of their relationship 
with nasal obstruction 
score and MCA.
REFERENCES
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Fig 1: Effect of 
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Fig 2: Sinus Cavity
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9.6 Poster 3: Association between rhinitis, asthma and some other major 
illness. (presenting author) 
Wang DY, Raza MT, Heng CK, Chan YH.  
The 5th Combined Scientific Meeting incorporating The 4th GSS-FOM Scientific 
Meeting, 12-14 May 2004, Clinical Research Centre, National University Singapore, 
Singapore. 
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Association between rhinitis,asthma and some major illness
1De Yun Wang, 1Md Tanveer Raza, 2Chew Kiat Heng, 3Yiong Huak Chan. 
Departments of Otolaryngology1 and Paediatrics2, Faculty of Medicine, The National University of Singapore. 3Clinical Trial & Epidemiology Research Unit, Singapore
BACKGROUND
Rhinitis is as an inflammation of the lining of the nose, 
characterized by one or more of the following symptoms, nasal 
congestion, rhinorrhea, sneezing & itching (1). It is often 
associated with multiple co-morbidities like asthma, sinusitis, 
anosmia, otitis media, nasal polyps, lower airway infection  & 
dental malocclusion, that might be due to different 
mechanisms such as a common genetic or epidemiological 
background, pathophysiological and functional interactions 
between rhinitis and surrounding organs. 
A French study reported that rhinitis is strongly associated 
with systolic blood pressure (SBP) and hypertension in men 
(2).
A population-based German study did not demonstrate such 
association between rhinits and blood pressure (3).
OBJECTIVE
To investigate the relationship between rhinitis, persistent 
allergic rhinitis (PAR), asthma and other major illness (e.g., 
hypertension, coronary arterial disease, diabetes) in Singapore.
METHOD
Volunteers were recruited from two previous studies: 
(1) A cohort of 214 adult subjects randomly selected to 
attend a national rhinitis survey study in the ENT out-patient 
clinic.
(2) 145 adult patients with PAR recruited for a clinical 
trial.






































**: Coronary artery disease
***HDL-C: High Density Lipoprotein-Cholesterol
****LDL-C: Low Density Lipoprotein-Cholesterol
†: Only confined to 1st degree relatives
Definitions used in this study
Atopy.A positive serum specific IgE (equal or more than 0.35U/ml) to 
at least one of the inhalant allergens tested.
Rhinitis. The occurrence of two or more symptoms (nasal obstruction, 
rhinorrhea, sneezing and itchy nose) on most days during the past year 
(1). If patients coexisted with atopy, PAR is given.
Asthma. A history of paroxysmal attacks of breathlessness commonly 
associated with a tightness of the chest and wheezing (1), and asthma 
was previously diagnosed by a physician.
Hypertension. Presence of at least one of the following conditions: 
SBP of 140 mmHg or greater, diastolic blood pressure (DBP) of 90
mm Hg or greater or taking antihypertensive medication.
Major illness. Presence of major illness, i.e., diabetes mellitus (DM) 
and coronary artery disease (CAD) was recorded if subjects presented 
with particular symptoms and were previously diagnosed by a 
physician.
RESULTS
Table 1. Significant association of rhinitis, allergic rhinitis, asthma and 
hypertension with medical history, diagnosis and all measurements by 
multiple logistic regression analysis.
_________________________________________________________
Name of disease
measurements p value Odds ratio 95% CI*
___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Rhinitis
Atopy 0.001 2.66 1.51 - 4.69
Asthma 0.001 4.35 1.77 - 10.69
HDL-C** 0.008 14.9 2.05 - 108.13
Age 0.003† 0.96 0.93 - 0.99
Persistent allergic rhinitis
Asthma <0.001 3.73 1.86 - 7.47
Age <0.001† 0.94 0.91 - 0.96
CAD*** 0.004 9.93 2.08 - 47.5
Diabetes 0.007† 0.13 0.03 - 0.57
BMI**** 0.022† 0.92 0.85 - 0.99 
Asthma
Rhinitis 0.001 4.62 1.85 - 11.54
BMI 0.003 1.14 1.05 - 1.24
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________
CI: Confidence Interval
*HDL-C: High Density Lipoprotein-Cholesterol
**CAD:  Coronary artery disease































Figure 2: Distribution of asthma and atopy patients in study population
Figure 3: Association between rhinitis, asthma and some major illness. Positive 
correlation             ; Negative Correlation







• There i  a strong association between rhinitis/PAR and asthma.
• Atopy is a highly associated factor for rhinitis, but not for asthma.
• Positive correlation between PAR and CAD
• Negative correlation between PAR and DM
• No association between SBP and DBP with rhinitis.
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